Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Submitted by
admin
on August 4, 2024 - 6:30pm
Source:
Motley Fool
News Tags:
AstraZeneca
Pharma CEOs
weight loss
obesity
Pascal Soriot
Headline:
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
snippet:
AstraZeneca's CEO has a vision for the weight loss drugs market.
There probably won't be one medicine that's useful in every niche.
He sees two big groupings of anti-obesity therapies worth focusing on.
Do Not Allow Advertisers to Use My Personal information